Skip To Main Content
Kayao Lau on Muck Rack

Kayao Lau

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Kayao

Contact Kayao, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Tumor-directed therapy in HR+ Breast Cancer oligoprogression to mutant selective PI3K-alpha inhibitor plus fulvestrant

|
By Hitomi Sumiyoshi Okuma, Haley Ellis, Eleni Zografos, Leontios Pappas, Steven J Isakoff, Dejan Juric, Andreas Varkaris, Allison Kehlmann, Kayao Lau
| Nature Verified
Abstract Oligoprogression poses a growing challenge in precision oncology. We report a case series of hormone receptor–positive/HER2-negative metastatic breast cancer patients treated with the selective PI3Kα inhibitor RLY-2608 who developed isolated progressive lesions.
Open in Who Shared Issue with article?
See all 1 articles